Real-time enrollment status for this advanced unresectable hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:09 PM UTC
| NCT Number | NCT07175441 |
| Recruiting Status | Recruiting |
| Condition | Advanced Unresectable Hepatocellular Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 220 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Riboscience, LLC. |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of August 31, 2026: Clinical trial NCT07175441 is currently recruiting participants. This phase2 study for advanced unresectable hepatocellular carcinoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Riboscience, LLC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07175441 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07175441 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.